The global veterinary orthopedic medicines market size is anticipated to reach USD 6.37 billion by 2030, registering a CAGR of 8.4% from 2024 to 2030. The increasing emergence of regenerative medicine and rise in the adoption of viscosupplementation products in veterinary medicine are the major factors contributing to market growth. According to a study conducted by Boehringer Ingelheim and the American Animal Hospital Association (AAHA), in 2022, 1 in 5 dogs i.e., 20% of all dogs experience some joint issue in their lifetime. The majority of animals suffer from Osteoarthritis (OA) because of Developmental Orthopedic Diseases (DODs), with certain breeds more prone to malformed joints than others. ![Global Veterinary Orthopedic Medicine Market]( "Global Veterinary Orthopedic Medicine Market")
The aim of regenerative medicine in veterinary medicine is to restore normal function to diseased or damaged cells, tissues, etc., including different approaches like cell-based therapies. The use of mesenchymal stromal cells (MSCs), platelet-rich plasma (PRP) & autologous serum products is prominent in this field. Currently, these therapies are used in tendon, ligament, and joint/cartilage treatment in animals like dogs, horses & cats. These treatments are primarily research-based and further concrete clinical reports are under progress. Irrespective of the current use, this branch of veterinary medicine promises effective treatment & management of veterinary diseases.
Current regenerative therapies like MSCs, PRP, etc., fall under the category of drugs. Therefore, FDS regulates them under the category “Cell-based Products”; however, no FDA approval has been given to any of these therapies till now, and the current use falls under FDA investigational exemption. Degenerative Joint Diseases (DJD) and OA cause a rise in friction in the joints. Viscosupplements, such as hyaluronic acid, are intra-articularly injected into the synovial joint of the animal, which further lubricates the joint to reduce friction and assist in smooth movement. Such initiatives are expected to help in the effective management of veterinary orthopedic conditions, thus driving market growth.
This product will be delivered within 1-3 business days.
The aim of regenerative medicine in veterinary medicine is to restore normal function to diseased or damaged cells, tissues, etc., including different approaches like cell-based therapies. The use of mesenchymal stromal cells (MSCs), platelet-rich plasma (PRP) & autologous serum products is prominent in this field. Currently, these therapies are used in tendon, ligament, and joint/cartilage treatment in animals like dogs, horses & cats. These treatments are primarily research-based and further concrete clinical reports are under progress. Irrespective of the current use, this branch of veterinary medicine promises effective treatment & management of veterinary diseases.
Current regenerative therapies like MSCs, PRP, etc., fall under the category of drugs. Therefore, FDS regulates them under the category “Cell-based Products”; however, no FDA approval has been given to any of these therapies till now, and the current use falls under FDA investigational exemption. Degenerative Joint Diseases (DJD) and OA cause a rise in friction in the joints. Viscosupplements, such as hyaluronic acid, are intra-articularly injected into the synovial joint of the animal, which further lubricates the joint to reduce friction and assist in smooth movement. Such initiatives are expected to help in the effective management of veterinary orthopedic conditions, thus driving market growth.
Veterinary Orthopedic Medicine Market Report Highlights
- The pharmaceuticals segment accounted for the highest revenue share of more than 51.8% in 2023 owing to the high adoption of products like NSAIDS, steroids, etc. in the treatment of veterinary orthopedic complications
- The canine segment is expected to grow at the fastest CAGR from 2024 to 2030
- The OA segment held the largest market share of 42.0% in 2023. The joint inflammation/pain segment is anticipated to witness the fastest CAGR from 2024 to 2030
- Use of viscosupplements like hyaluronic acid and rising adoption of stem-cell therapy in veterinary complications contributed to market growth
- North America led the market owing to factors, such as increasing prevalence of osteoarthritis, well-equipped veterinary care infrastructure, government support for quality animal care, and high pet adoption in the U.S.
- In August 2022, Bimeda U.S. acquired Afrivet Southern Africa Proprietary Limited, a part of Bimeda’s ongoing expansion program to increase its geographic footprint
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.5. Details of Primary Research
1.5.1. Data for Primary Interviews in North America
1.5.2. Data for Primary Interviews in Europe
1.5.3. Data for Primary Interviews in Asia-Pacific
1.5.4. Data for Primary Interviews in Latin America
1.5.5. Data for Primary Interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Parent Market Analysis (Model 1)
1.7.1.1. Approach 1: Parent Market approach
1.7.2. Company Share Analysis (Model 2)
1.7.2.1. Approach 2: Company Share approach
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.5. Details of Primary Research
1.5.1. Data for Primary Interviews in North America
1.5.2. Data for Primary Interviews in Europe
1.5.3. Data for Primary Interviews in Asia-Pacific
1.5.4. Data for Primary Interviews in Latin America
1.5.5. Data for Primary Interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Parent Market Analysis (Model 1)
1.7.1.1. Approach 1: Parent Market approach
1.7.2. Company Share Analysis (Model 2)
1.7.2.1. Approach 2: Company Share approach
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Orthopedic Medicine Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Emergence of Regenerative Medicine
3.2.1.2. Increasing Adoption of Viscosupplementation Products in Treatment of Musculoskeletal Disorders
3.2.1.3. Rise in Prevalence of Osteoarthritis and other Degenerative Joint Diseases
3.2.1.4. Rising Adoption of Stem Cell Therapy and Other Biologics in Veterinary Medicine
3.2.2. Market Restraints Analysis
3.2.2.1. Low Penetration of Importance of Veterinary Care in Under-developed Countries
3.2.2.2. Thorough Regulatory Scrutiny
3.3. Veterinary Orthopedic Medicine Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining Power of The Suppliers
3.3.1.2. Bargaining Power of the Buyers
3.3.1.3. Threats of Substitution
3.3.1.4. Threats from New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological Landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Emergence of Regenerative Medicine
3.2.1.2. Increasing Adoption of Viscosupplementation Products in Treatment of Musculoskeletal Disorders
3.2.1.3. Rise in Prevalence of Osteoarthritis and other Degenerative Joint Diseases
3.2.1.4. Rising Adoption of Stem Cell Therapy and Other Biologics in Veterinary Medicine
3.2.2. Market Restraints Analysis
3.2.2.1. Low Penetration of Importance of Veterinary Care in Under-developed Countries
3.2.2.2. Thorough Regulatory Scrutiny
3.3. Veterinary Orthopedic Medicine Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining Power of The Suppliers
3.3.1.2. Bargaining Power of the Buyers
3.3.1.3. Threats of Substitution
3.3.1.4. Threats from New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological Landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
Chapter 4. Veterinary Orthopedic Medicine Market: Product type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Veterinary Orthopedic Medicine Market: Solution Movement Analysis, USD Million, 2023 & 2030
4.3. Biologics
4.3.1. Biologics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Viscosupplements
4.4.1. Viscosupplements Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Pharmaceuticals
4.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.2. Veterinary Orthopedic Medicine Market: Solution Movement Analysis, USD Million, 2023 & 2030
4.3. Biologics
4.3.1. Biologics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Viscosupplements
4.4.1. Viscosupplements Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Pharmaceuticals
4.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Veterinary Orthopedic Medicine Market: Animal type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Canine
5.3.1. Canine Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Feline
5.4.1. Feline Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Equine
5.5.1. Equine Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Cattle
5.6.1. Cattle Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Swine
5.7.1. Swine Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Canine
5.3.1. Canine Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Feline
5.4.1. Feline Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Equine
5.5.1. Equine Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Cattle
5.6.1. Cattle Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Swine
5.7.1. Swine Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Veterinary Orthopedic Medicine Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Osteoarthritis
6.3.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Degenerative Joint Disease (DJD)
6.4.1. Degenerative Joint Disease (DJD) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Joint Inflammation/Pain
6.5.1. Joint Inflammation/Pain Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Other Applications
6.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Osteoarthritis
6.3.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Degenerative Joint Disease (DJD)
6.4.1. Degenerative Joint Disease (DJD) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Joint Inflammation/Pain
6.5.1. Joint Inflammation/Pain Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Other Applications
6.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Veterinary Orthopedic Medicine Market: Route of Administration Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
7.3. Oral
7.3.1. Oral Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Parenteral
7.4.1. Parenteral Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Topical
7.5.1. Topical Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
7.3. Oral
7.3.1. Oral Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Parenteral
7.4.1. Parenteral Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Topical
7.5.1. Topical Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Veterinary Orthopedic Medicine Market: End-use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Veterinary Orthopedic Medicine Market: End-user Movement Analysis, USD Million, 2023 & 2030
8.3. Veterinary Hospitals
8.3.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Veterinary Clinics
8.4.1. Veterinary Clinics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Others
8.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
8.2. Veterinary Orthopedic Medicine Market: End-user Movement Analysis, USD Million, 2023 & 2030
8.3. Veterinary Hospitals
8.3.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Veterinary Clinics
8.4.1. Veterinary Clinics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Others
8.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Veterinary Orthopedic Medicine Market: Regional Estimates & Trend Analysis
9.1. Veterinary Orthopedic Medicine Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. U.S. Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. Canada Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3. Europe
9.3.1. Europe Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Regulatory Landscape/Reimbursement Scenario
9.3.2.3. Competitive Insights
9.3.2.4. UK Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Regulatory Landscape/Reimbursement Scenario
9.3.3.3. Competitive Insights
9.3.3.4. Germany Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Regulatory Landscape/Reimbursement Scenario
9.3.4.3. Competitive Insights
9.3.4.4. France Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Regulatory Landscape/Reimbursement Scenario
9.3.5.3. Competitive Insights
9.3.5.4. Italy Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Regulatory Landscape/Reimbursement Scenario
9.3.6.3. Competitive Insights
9.3.6.4. Spain Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Regulatory Landscape/Reimbursement Scenario
9.3.7.3. Competitive Insights
9.3.7.4. Denmark Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Regulatory Landscape/Reimbursement Scenario
9.3.8.3. Competitive Insights
9.3.8.4. Sweden Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Regulatory Landscape/Reimbursement Scenario
9.3.9.3. Competitive Insights
9.3.9.4. Norway Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4. Asia-Pacific
9.4.1. Asia-Pacific Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Landscape/Reimbursement Scenario
9.4.2.3. Competitive Insights
9.4.2.4. Japan Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Landscape/Reimbursement Scenario
9.4.3.3. Competitive Insights
9.4.3.4. China Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Landscape/Reimbursement Scenario
9.4.4.3. Competitive Insights
9.4.4.4. India Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Regulatory Landscape/Reimbursement Scenario
9.4.5.3. Competitive Insights
9.4.5.4. Australia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.6. Thailand
9.4.6.1. Key Country Dynamics
9.4.6.2. Regulatory Landscape/Reimbursement Scenario
9.4.6.3. Competitive Insights
9.4.6.4. Thailand Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.7. South Korea
9.4.7.1. Key Country Dynamics
9.4.7.2. Regulatory Landscape/Reimbursement Scenario
9.4.7.3. Competitive Insights
9.4.7.4. South Korea Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Landscape/Reimbursement Scenario
9.5.2.3. Competitive Insights
9.5.2.4. Brazil Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Landscape/Reimbursement Scenario
9.5.3.3. Competitive Insights
9.5.3.4. Mexico Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Landscape/Reimbursement Scenario
9.5.4.3. Competitive Insights
9.5.4.4. Argentina Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Landscape/Reimbursement Scenario
9.6.2.3. Competitive Insights
9.6.2.4. South Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Landscape/Reimbursement Scenario
9.6.3.3. Competitive Insights
9.6.3.4. Saudi Arabia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Landscape/Reimbursement Scenario
9.6.4.3. Competitive Insights
9.6.4.4. UAE Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Landscape/Reimbursement Scenario
9.6.5.3. Competitive Insights
9.6.5.4. Kuwait Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2. North America
9.2.1. North America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. U.S. Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. Canada Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3. Europe
9.3.1. Europe Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Regulatory Landscape/Reimbursement Scenario
9.3.2.3. Competitive Insights
9.3.2.4. UK Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Regulatory Landscape/Reimbursement Scenario
9.3.3.3. Competitive Insights
9.3.3.4. Germany Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Regulatory Landscape/Reimbursement Scenario
9.3.4.3. Competitive Insights
9.3.4.4. France Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Regulatory Landscape/Reimbursement Scenario
9.3.5.3. Competitive Insights
9.3.5.4. Italy Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Regulatory Landscape/Reimbursement Scenario
9.3.6.3. Competitive Insights
9.3.6.4. Spain Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Regulatory Landscape/Reimbursement Scenario
9.3.7.3. Competitive Insights
9.3.7.4. Denmark Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Regulatory Landscape/Reimbursement Scenario
9.3.8.3. Competitive Insights
9.3.8.4. Sweden Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Regulatory Landscape/Reimbursement Scenario
9.3.9.3. Competitive Insights
9.3.9.4. Norway Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4. Asia-Pacific
9.4.1. Asia-Pacific Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Landscape/Reimbursement Scenario
9.4.2.3. Competitive Insights
9.4.2.4. Japan Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Landscape/Reimbursement Scenario
9.4.3.3. Competitive Insights
9.4.3.4. China Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Landscape/Reimbursement Scenario
9.4.4.3. Competitive Insights
9.4.4.4. India Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Regulatory Landscape/Reimbursement Scenario
9.4.5.3. Competitive Insights
9.4.5.4. Australia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.6. Thailand
9.4.6.1. Key Country Dynamics
9.4.6.2. Regulatory Landscape/Reimbursement Scenario
9.4.6.3. Competitive Insights
9.4.6.4. Thailand Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.7. South Korea
9.4.7.1. Key Country Dynamics
9.4.7.2. Regulatory Landscape/Reimbursement Scenario
9.4.7.3. Competitive Insights
9.4.7.4. South Korea Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Landscape/Reimbursement Scenario
9.5.2.3. Competitive Insights
9.5.2.4. Brazil Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Landscape/Reimbursement Scenario
9.5.3.3. Competitive Insights
9.5.3.4. Mexico Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Landscape/Reimbursement Scenario
9.5.4.3. Competitive Insights
9.5.4.4. Argentina Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Landscape/Reimbursement Scenario
9.6.2.3. Competitive Insights
9.6.2.4. South Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Landscape/Reimbursement Scenario
9.6.3.3. Competitive Insights
9.6.3.4. Saudi Arabia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Landscape/Reimbursement Scenario
9.6.4.3. Competitive Insights
9.6.4.4. UAE Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Landscape/Reimbursement Scenario
9.6.5.3. Competitive Insights
9.6.5.4. Kuwait Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Market Share Analysis
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research And Development
10.6. Company Profiles
10.6.1. Zoetis, Inc.
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. Boehringer Ingelheim
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. Elanco Animal Health
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. American Regent, Inc.
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. Merck Animal Health (Merck & Co. Inc.)
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. Vetoquinol S.A.
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Ceva Sante Animale
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. Virbac
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Biogenesis Bago
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Ardent Animal Health Llc.
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments
10.6.11. Bioiberica S.A.U
10.6.11.1. Participant’s Overview
10.6.11.2. Financial Performance
10.6.11.3. Product Benchmarking
10.6.11.4. Recent Developments
10.6.12. PetVivo Holdings, Inc. (Spryng)
10.6.12.1. Participant’s Overview
10.6.12.2. Financial Performance
10.6.12.3. Product Benchmarking
10.6.12.4. Recent Developments
10.6.13. Contipro A.S.
10.6.13.1. Participant’s Overview
10.6.13.2. Financial Performance
10.6.13.3. Product Benchmarking
10.6.13.4. Recent Developments
10.6.14. VetStem, Inc.
10.6.14.1. Participant’s Overview
10.6.14.2. Financial Performance
10.6.14.3. Product Benchmarking
10.6.14.4. Recent Developments
10.6.15. Enso Discoveries
10.6.15.1. Participant’s Overview
10.6.15.2. Financial Performance
10.6.15.3. Product Benchmarking
10.6.15.4. Recent Developments
10.6.16. Contura Vet US
10.6.16.1. Participant’s Overview
10.6.16.2. Financial Performance
10.6.16.3. Product Benchmarking
10.6.16.4. Recent Developments
10.6.17. T-Cyte Therepeutics
10.6.17.1. Participant’s Overview
10.6.17.2. Financial Performance
10.6.17.3. Product Benchmarking
10.6.17.4. Recent Developments
10.6.18. MEDREGO LLC
10.6.18.1. Participant’s Overview
10.6.18.2. Financial Performance
10.6.18.3. Product Benchmarking
10.6.18.4. Recent Developments
10.6.19. Bimeda U.S.
10.6.19.1. Participant’s Overview
10.6.19.2. Financial Performance
10.6.19.3. Product Benchmarking
10.6.19.4. Recent Developments
10.6.20. Hyalogic
10.6.20.1. Participant’s Overview
10.6.20.2. Financial Performance
10.6.20.3. Product Benchmarking
10.6.20.4. Recent Developments
10.6.21. Hester Biosciences
10.6.21.1. Participant’s Overview
10.6.21.2. Financial Performance
10.6.21.3. Product Benchmarking
10.6.21.4. Recent Developments
10.2. Company Categorization
10.3. Company Market Share Analysis
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research And Development
10.6. Company Profiles
10.6.1. Zoetis, Inc.
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. Boehringer Ingelheim
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. Elanco Animal Health
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. American Regent, Inc.
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. Merck Animal Health (Merck & Co. Inc.)
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. Vetoquinol S.A.
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Ceva Sante Animale
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. Virbac
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Biogenesis Bago
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Ardent Animal Health Llc.
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments
10.6.11. Bioiberica S.A.U
10.6.11.1. Participant’s Overview
10.6.11.2. Financial Performance
10.6.11.3. Product Benchmarking
10.6.11.4. Recent Developments
10.6.12. PetVivo Holdings, Inc. (Spryng)
10.6.12.1. Participant’s Overview
10.6.12.2. Financial Performance
10.6.12.3. Product Benchmarking
10.6.12.4. Recent Developments
10.6.13. Contipro A.S.
10.6.13.1. Participant’s Overview
10.6.13.2. Financial Performance
10.6.13.3. Product Benchmarking
10.6.13.4. Recent Developments
10.6.14. VetStem, Inc.
10.6.14.1. Participant’s Overview
10.6.14.2. Financial Performance
10.6.14.3. Product Benchmarking
10.6.14.4. Recent Developments
10.6.15. Enso Discoveries
10.6.15.1. Participant’s Overview
10.6.15.2. Financial Performance
10.6.15.3. Product Benchmarking
10.6.15.4. Recent Developments
10.6.16. Contura Vet US
10.6.16.1. Participant’s Overview
10.6.16.2. Financial Performance
10.6.16.3. Product Benchmarking
10.6.16.4. Recent Developments
10.6.17. T-Cyte Therepeutics
10.6.17.1. Participant’s Overview
10.6.17.2. Financial Performance
10.6.17.3. Product Benchmarking
10.6.17.4. Recent Developments
10.6.18. MEDREGO LLC
10.6.18.1. Participant’s Overview
10.6.18.2. Financial Performance
10.6.18.3. Product Benchmarking
10.6.18.4. Recent Developments
10.6.19. Bimeda U.S.
10.6.19.1. Participant’s Overview
10.6.19.2. Financial Performance
10.6.19.3. Product Benchmarking
10.6.19.4. Recent Developments
10.6.20. Hyalogic
10.6.20.1. Participant’s Overview
10.6.20.2. Financial Performance
10.6.20.3. Product Benchmarking
10.6.20.4. Recent Developments
10.6.21. Hester Biosciences
10.6.21.1. Participant’s Overview
10.6.21.2. Financial Performance
10.6.21.3. Product Benchmarking
10.6.21.4. Recent Developments
List of Tables
Table 1 Veterinary Orthopedic Medicine(Veterinary Orthopedic Medicine) market 2018-2030 (USD Million)
Table 2 Global market estimates and forecasts by region, 2018-2030 (USD Million)
Table 3 Global market estimates and forecasts By Product type, 2018-2030 (USD Million)
Table 4 Global market estimates and forecasts By Animal type, 2018-2030 (USD Million)
Table 5 Global market estimates and forecasts By Application, 2018-2030 (USD Million)
Table 6 Global market estimates and forecasts By Route of Administration, 2018-2030 (USD Million)
Table 7 Global market estimates and forecasts by End-use, 2018-2030 (USD Million)
Table 8 Veterinary Orthopedic Medicine- M&A, collaborations & partnership scenario
Table 9 Biologics Veterinary Orthopedic Medicine market by region, 2018-2030 (USD Million)
Table 10 Viscosupplements Veterinary Orthopedic Medicine market by region, 2018-2030 (USD Million)
Table 11 Pharmaceuticals Veterinary Orthopedic Medicine market by region, 2018-2030 (USD Million)
Table 12 Veterinary Orthopedic Medicine Canine market by region, 2018-2030 (USD Million)
Table 13 Veterinary Orthopedic Medicine Feline market by region, 2018-2030 (USD Million)
Table 14 Veterinary Orthopedic Medicine Equine market by region, 2018-2030 (USD Million)
Table 15 Veterinary Orthopedic Medicine Cattle market by region, 2018-2030 (USD Million)
Table 16 Veterinary Orthopedic Medicine Swine market by region, 2018-2030 (USD Million)
Table 17 Veterinary orthopedic medicine Osteoarthrtitis market, by use case, 2018-2030, (USD Million)
Table 18 Veterinary Orthopedic Medicine Degenerative Joint Diseases (DJD) market by region, 2018-2030 (USD Million)
Table 19 Veterinary orthopedic medicine Joint Inflammation/Pain market, by region 2018-2030, (USD Million)
Table 20 Veterinary Orthopedic Medicine Oral by region, 2018-2030 (USD Million)
Table 21 Veterinary Orthopedic Medicine Parenteral market by region, 2018-2030 (USD Million)
Table 22 Veterinary Orthopedic Topical market by region, 2018-2030 (USD Million)
Table 23 Veterinary Orthopedic Medicine Veterinary Hospitals market by region, 2018-2030 (USD Million)
Table 24 Veterinary Orthopedic Medicine Veterinary Clinics market by region, 2018-2030 (USD Million)
Table 25 North America Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 26 North America Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 27 North America Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 28 North America Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 29 North America Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 30 U.S. Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 31 U.S. Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 32 U.S. Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 33 U.S. Veterinary Orthopedic Medicine market By Route of Administration, 2018 -
Table 34 U.S. Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 35 Canada Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 36 Canada Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 37 Canada Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 38 Canada Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 39 Canada Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 40 Mexico Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 41 Mexico Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 42 Mexico Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 43 Mexico Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 44 Mexico Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 45 Europe Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 46 Europe Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 47 Europe Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 48 Europe Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 49 Europe Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 50 Germany Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 51 Germany Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 52 Germany Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 53 Germany Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 54 Germany Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 55 UK Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 56 UK Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 57 UK Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 58 UK Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 59 UK Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 60 Asia-Pacific Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 61 Asia-Pacific Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 62 Asia-Pacific Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 63 Asia-Pacific Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 64 Asia-Pacific Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 65 China Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 66 China Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 67 China Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 68 China Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 69 China Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 70 Japan Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 71 Japan Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 72 Japan Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 73 Japan Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 74 Japan Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 75 India Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 76 India Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 77 India Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 78 India Veterinary Orthopedic Medicine market By Route of Aministration, 2018-2030 (USD Million)
Table 79 India Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 80 South Koreaa Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 81 South Korea Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 82 South Korea Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 83 South Korea Veterinary Orthopedic Medicine market By Route of Aministration, 2018-2030 (USD Million)
Table 84 South Korea Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 85 Brazil Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 86 Brazil Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 87 Brazil Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 88 Brazil Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 89 Brazil Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 90 Middle East & Africa Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 91 Middle East & Africa Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 92 Middle East & Africa Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 93 Middle East & Africa Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 94 Middle East & Africa Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 2 Global market estimates and forecasts by region, 2018-2030 (USD Million)
Table 3 Global market estimates and forecasts By Product type, 2018-2030 (USD Million)
Table 4 Global market estimates and forecasts By Animal type, 2018-2030 (USD Million)
Table 5 Global market estimates and forecasts By Application, 2018-2030 (USD Million)
Table 6 Global market estimates and forecasts By Route of Administration, 2018-2030 (USD Million)
Table 7 Global market estimates and forecasts by End-use, 2018-2030 (USD Million)
Table 8 Veterinary Orthopedic Medicine- M&A, collaborations & partnership scenario
Table 9 Biologics Veterinary Orthopedic Medicine market by region, 2018-2030 (USD Million)
Table 10 Viscosupplements Veterinary Orthopedic Medicine market by region, 2018-2030 (USD Million)
Table 11 Pharmaceuticals Veterinary Orthopedic Medicine market by region, 2018-2030 (USD Million)
Table 12 Veterinary Orthopedic Medicine Canine market by region, 2018-2030 (USD Million)
Table 13 Veterinary Orthopedic Medicine Feline market by region, 2018-2030 (USD Million)
Table 14 Veterinary Orthopedic Medicine Equine market by region, 2018-2030 (USD Million)
Table 15 Veterinary Orthopedic Medicine Cattle market by region, 2018-2030 (USD Million)
Table 16 Veterinary Orthopedic Medicine Swine market by region, 2018-2030 (USD Million)
Table 17 Veterinary orthopedic medicine Osteoarthrtitis market, by use case, 2018-2030, (USD Million)
Table 18 Veterinary Orthopedic Medicine Degenerative Joint Diseases (DJD) market by region, 2018-2030 (USD Million)
Table 19 Veterinary orthopedic medicine Joint Inflammation/Pain market, by region 2018-2030, (USD Million)
Table 20 Veterinary Orthopedic Medicine Oral by region, 2018-2030 (USD Million)
Table 21 Veterinary Orthopedic Medicine Parenteral market by region, 2018-2030 (USD Million)
Table 22 Veterinary Orthopedic Topical market by region, 2018-2030 (USD Million)
Table 23 Veterinary Orthopedic Medicine Veterinary Hospitals market by region, 2018-2030 (USD Million)
Table 24 Veterinary Orthopedic Medicine Veterinary Clinics market by region, 2018-2030 (USD Million)
Table 25 North America Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 26 North America Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 27 North America Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 28 North America Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 29 North America Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 30 U.S. Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 31 U.S. Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 32 U.S. Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 33 U.S. Veterinary Orthopedic Medicine market By Route of Administration, 2018 -
Table 34 U.S. Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 35 Canada Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 36 Canada Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 37 Canada Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 38 Canada Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 39 Canada Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 40 Mexico Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 41 Mexico Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 42 Mexico Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 43 Mexico Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 44 Mexico Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 45 Europe Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 46 Europe Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 47 Europe Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 48 Europe Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 49 Europe Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 50 Germany Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 51 Germany Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 52 Germany Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 53 Germany Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 54 Germany Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 55 UK Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 56 UK Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 57 UK Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 58 UK Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 59 UK Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 60 Asia-Pacific Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 61 Asia-Pacific Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 62 Asia-Pacific Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 63 Asia-Pacific Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 64 Asia-Pacific Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 65 China Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 66 China Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 67 China Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 68 China Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 69 China Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 70 Japan Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 71 Japan Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 72 Japan Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 73 Japan Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 74 Japan Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 75 India Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 76 India Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 77 India Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 78 India Veterinary Orthopedic Medicine market By Route of Aministration, 2018-2030 (USD Million)
Table 79 India Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 80 South Koreaa Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 81 South Korea Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 82 South Korea Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 83 South Korea Veterinary Orthopedic Medicine market By Route of Aministration, 2018-2030 (USD Million)
Table 84 South Korea Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 85 Brazil Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 86 Brazil Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 87 Brazil Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 88 Brazil Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 89 Brazil Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
Table 90 Middle East & Africa Veterinary Orthopedic Medicine market By Product type, 2018-2030 (USD Million)
Table 91 Middle East & Africa Veterinary Orthopedic Medicine market By Animal type, 2018-2030 (USD Million)
Table 92 Middle East & Africa Veterinary Orthopedic Medicine market By Application, 2018-2030 (USD Million)
Table 93 Middle East & Africa Veterinary Orthopedic Medicine market By Route of Administration, 2018-2030 (USD Million)
Table 94 Middle East & Africa Veterinary Orthopedic Medicine market by end-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Veterinary Orthopedic Medicine Market Segmentation
Figure 2 Disease Epidemiology
Figure 3 Information Procurement
Figure 4 Data Analysis Models
Figure 5 Market Formulation and Validation
Figure 6 Data Validating & Publishing
Figure 7 Market Snapshot
Figure 8 Segment Snapshot (1/2)
Figure 9 Segment Snapshot (2/2)
Figure 10 Competitive Landscape Snapshot
Figure 11 Veterinary Orthopedic Medicine - Market Size and Growth Prospects (USD Million)
Figure 12 Veterinary Orthopedic Medicine Market: Industry Value Chain Analysis
Figure 13 Veterinary Orthopedic Medicine Market: Market Dynamics
Figure 14 Veterinary Orthopedic Medicine Market: PORTER’s Analysis
Figure 15 Veterinary Orthopedic Medicine Market: PESTEL Analysis
Figure 16 Veterinary Orthopedic Medicine Market Share By Product type, 2023 & 2030 (USD Million)
Figure 17 Veterinary Orthopedic Medicine Market, By Product type: Market Share, 2023 & 2030
Figure 18 Biologics Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 19 Viscosupplements Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 20 Pharmaceuticals Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 21 Veterinary Orthopedic Medicine Market Share By Animal type, 2023 & 2030 (USD Million)
Figure 22 Veterinary Orthopedic Medicine Market, By Animal type: Market Share, 2023 & 2030
Figure 23 Canine Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 24 Feline Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 25 Equine Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 26 Cattle Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 27 Swine Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 28 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 29 Veterinary Orthopedic Medicine Market Share By Application, 2023 & 2030 (USD Million)
Figure 30 Veterinary Orthopedic Medicine Market, By Application: Market Share, 2023 & 2030
Figure 31 Osteoarthritis Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 32 Dengenerative Joint Diseases (DJD) Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 33 Joint Inflammaition/Pain Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 34 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 35 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 36 Veterinary Orthopedic Medicine Market Share By Route of Administration, 2023 & 2030 (USD Million)
Figure 37 Veterinary Orthopedic Medicine Market, By Route of Administration: Market Share, 2023 & 2030
Figure 38 Oral Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 39 Parenteral Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 40 Veterinary Orthopedic Medicine Market, by End-Use: Key Takeaways
Figure 41 Veterinary Orthopedic Medicine Market, by End-Use: Market Share, 2023 & 2030
Figure 42 Veterinary Hospitals Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 43 Veterinary Clinics Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 44 Other Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 45 Veterinary Orthopedic Medicine Market Revenue, by Region, 2023 & 2030, (USD Million)
Figure 46 Regional Marketplace: Key Takeaways
Figure 47 Regional Marketplace: Key Takeaways
Figure 48 North America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 U.S. Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Canada Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Europe Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 UK Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
Figure 53 Germany Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 France Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Italy Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 Spain Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Denmark Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 Sweden Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Norway Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 Asia-Pacific Veterinary Orthopedic Medicine Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 61 China Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Japan Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 India Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 South Korea Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Australia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 Thailand Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 67 Latin America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 Brazil Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 69 Mexico Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 70 Argentina Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 71 MEA Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 KSA Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 73 UAE Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 South Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 75 Kuwait Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Key Company Categorization
Figure 77 Company Market Positioning
Figure 78 Key Company Market Share Analysis, 2023
Figure 79 Strategic Framework
Figure 2 Disease Epidemiology
Figure 3 Information Procurement
Figure 4 Data Analysis Models
Figure 5 Market Formulation and Validation
Figure 6 Data Validating & Publishing
Figure 7 Market Snapshot
Figure 8 Segment Snapshot (1/2)
Figure 9 Segment Snapshot (2/2)
Figure 10 Competitive Landscape Snapshot
Figure 11 Veterinary Orthopedic Medicine - Market Size and Growth Prospects (USD Million)
Figure 12 Veterinary Orthopedic Medicine Market: Industry Value Chain Analysis
Figure 13 Veterinary Orthopedic Medicine Market: Market Dynamics
Figure 14 Veterinary Orthopedic Medicine Market: PORTER’s Analysis
Figure 15 Veterinary Orthopedic Medicine Market: PESTEL Analysis
Figure 16 Veterinary Orthopedic Medicine Market Share By Product type, 2023 & 2030 (USD Million)
Figure 17 Veterinary Orthopedic Medicine Market, By Product type: Market Share, 2023 & 2030
Figure 18 Biologics Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 19 Viscosupplements Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 20 Pharmaceuticals Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 21 Veterinary Orthopedic Medicine Market Share By Animal type, 2023 & 2030 (USD Million)
Figure 22 Veterinary Orthopedic Medicine Market, By Animal type: Market Share, 2023 & 2030
Figure 23 Canine Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 24 Feline Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 25 Equine Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 26 Cattle Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 27 Swine Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 28 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 29 Veterinary Orthopedic Medicine Market Share By Application, 2023 & 2030 (USD Million)
Figure 30 Veterinary Orthopedic Medicine Market, By Application: Market Share, 2023 & 2030
Figure 31 Osteoarthritis Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 32 Dengenerative Joint Diseases (DJD) Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 33 Joint Inflammaition/Pain Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 34 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 35 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 36 Veterinary Orthopedic Medicine Market Share By Route of Administration, 2023 & 2030 (USD Million)
Figure 37 Veterinary Orthopedic Medicine Market, By Route of Administration: Market Share, 2023 & 2030
Figure 38 Oral Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 39 Parenteral Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 40 Veterinary Orthopedic Medicine Market, by End-Use: Key Takeaways
Figure 41 Veterinary Orthopedic Medicine Market, by End-Use: Market Share, 2023 & 2030
Figure 42 Veterinary Hospitals Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 43 Veterinary Clinics Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 44 Other Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 45 Veterinary Orthopedic Medicine Market Revenue, by Region, 2023 & 2030, (USD Million)
Figure 46 Regional Marketplace: Key Takeaways
Figure 47 Regional Marketplace: Key Takeaways
Figure 48 North America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 U.S. Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Canada Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Europe Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 UK Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
Figure 53 Germany Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 France Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Italy Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 Spain Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Denmark Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 Sweden Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Norway Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 Asia-Pacific Veterinary Orthopedic Medicine Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 61 China Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Japan Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 India Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 South Korea Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Australia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 Thailand Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 67 Latin America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 Brazil Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 69 Mexico Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 70 Argentina Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 71 MEA Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 KSA Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 73 UAE Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 South Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 75 Kuwait Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Key Company Categorization
Figure 77 Company Market Positioning
Figure 78 Key Company Market Share Analysis, 2023
Figure 79 Strategic Framework
Companies Mentioned
- Zoetis, Inc.
- Boehringer Ingelheim
- Elanco Animal Health
- American Regent, Inc.
- Merck Animal Health (Merck & Co. Inc.)
- Vetoquinol S.A.
- Ceva Sante Animale
- Virbac
- Biogenesis Bago
- Ardent Animal Health Llc.
- Bioiberica S.A.U
- PetVivo Holdings, Inc. (Spryng)
- Contipro A.S.
- VetStem, Inc.
- Enso Discoveries
- Contura Vet US
- T-Cyte Therepeutics
- MEDREGO LLC
- Bimeda U.S.
- Hyalogic
- Hester Biosciences
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | December 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 3.62 Billion |
| Forecasted Market Value ( USD | $ 6.37 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
